Triazolam treatment controversy.
Ghaeli
P
P
University of Rhode Island, Providence.
Dufresne
R L
RL
Stoukides
C A
CA
D017277:Drug Approval / Q000331:legislation & jurisprudence* / Q000379:methods; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards*; D006801:Humans; D011605:Psychoses, Substance-Induced / Q000209:etiology; D014229:Triazolam / Q000009:adverse effects* / Q000627:therapeutic use; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration
D014229:Triazolam